Nalaganje...
Isolation and characterization of erlotinib-resistant human non-small cell lung cancer A549 cells
Erlotinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, is an effective therapy for non-small cell lung cancer (NSCLC). However, resistance to erlotinib reduces its efficacy. To investigate the basis of erlotinib resistance, we isolated erlotinib-resistant human NSCLC A549 c...
Shranjeno v:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
D.A. Spandidos
2011
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3412472/ https://ncbi.nlm.nih.gov/pubmed/22870135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2010.198 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|